Advisory Board and Editors Medical Genetics
Ranjit Vijayan
Dr. Ranjit Vijayan obtained his PhD in Life Sciences Interface/Biochemistry from the University of Oxford, UK, and his DipGrad in Management from the London School of Economics & Political Science, University of London, UK. In 2004 Dr Vijayan obtained his MSc in Computer Science from the University of Wales, Aberystwyth, UK, and prior to this his BEng in Electrical & Electronic Engineering, Nanyang Technological University, Singapore.
Dr. Vijayan's research interests include; molecular dynamics simulations of biological macromolecules, protein structure modeling, structure based drug discovery, genomics & transcriptomics, pharmacogenomics and high-performance computing.
Shibiao Wan
Dr. Shibiao Wan is currently an Assistant Professor in the Department of Genetics, Cell Biology and Anatomy at University of Nebraska Medical Center (UNMC). He is also the Assistant Director for Bioinformatics and Systems Biology Core at UNMC.
With more than 14 years of experience in machine learning, bioinformatics, and computational biology, Dr. Wan has published >50 articles in top-tiered journals such as Genome Research, Nature Communications, Science Advances, Circulation Research, Briefings in Bioinformatics, and Bioinformatics. Dr. Wan is the Editor-in-Chief for Current Proteomics, and an Editorial Board Member for a series of prestigious journals such as Briefings in Functional Genomics, Heliyon, BMC Bioinformatics, International Journal of Microbiology, PeerJ Computer Science, BioMed Research International, and Computational and Mathematical Methods, and a guest associate editor for multiple high-impact journals including Frontiers in Immunology, Frontiers in Cell and Developmental Biology, Frontiers in Pharmacology, Biology, Frontiers in Genetics, and Genes.
Dr Wan is a TPC member for >20 machine learning related international conferences including IEEE ICTAI. Dr. Wan is also a reviewer for >50 prestigious journals including Nature Methods, Nature Communications, Nature Computational Science, Nucleic Acids Research, Cancer Research, Genome Medicine, and Briefings in Bioinformatics. Dr. Wan has received a number of accolades including the New Investigator Award in 2024 by UNMC, the FIRST Award in 2023 by Nebraska EPSCoR, the Outstanding Young Alumni Award in 2022 by HK PolyU as well as the Global Peer Review Awards (top 1%) in “Cross-Field” and “Biology and Biochemistry” in 2019 awarded by Clarivate. Dr. Wan is a member of AACR, ISCB and ACM and an IEEE Senior Member.
Albert HC Wong
Albert H.C. Wong is a neuroscientist and psychiatrist at the Centre for Addiction and Mental Health, and a Professor at the University of Toronto. He attended medical school at the University of Toronto, where he also completed specialty training in psychiatry and a PhD in neurobiology. Dr. Wong’s lab uses animal models and clinical studies to investigate genetic, epigenetic and developmental mechanisms of psychiatric disease. His areas of clinical expertise are in schizophrenia and brain stimulation.
Joseph C Wu
Joseph C. Wu, MD, PhD is Director of the Stanford Cardiovascular Institute and Simon H. Stertzer Professor of Medicine (Cardiology) and Radiology at the Stanford School of Medicine. Dr. Wu received his MD from Yale University School of Medicine. He trained in internal medicine and cardiology at UCLA followed by a PhD in the Dept of Molecular Pharmacology. His clinical interests involve cardiovascular imaging and adult congenital heart disease. His lab works on biological mechanisms of patient-specific and disease-specific induced pluripotent stem cells (iPSCs). The main goals are to (i) understand basic cardiovascular disease mechanisms, (ii) accelerate drug discovery and screening, (iii) develop “clinical trial in a dish” concept, and (iv) implement precision cardiovascular medicine for prevention and treatment of patients. His lab uses a combination of genomics, stem cells, cellular & molecular biology, physiological testing, and molecular imaging technologies to better understand molecular and pathophysiological processes.
Venkata Yellapantula
Bioinformatician currently at Memorial Loan Kettering Cancer Center with 10 years of experience in analyzing high-throughput genomic and proteomic data. I have a diverse background in handling raw exome & whole genome sequencing, RNA-Seq and ChIP-Seq data to identify genetic aberrations. Proficient in development and implementing pipelines and algorithms and post analysis of aberrations identified through individual assays to glean novel biological patterns. Led large-scalegenomic efforts such as MMRF CoMMpass trial, ICGC & TCGA.
Jian Zhang
Dr. Jian Zhang currently works at the Division of Gastrointestinal Surgery & Gastric Cancer Center, The First Affiliated Hospital of Sun Yat-sen University. Jian does research in Genetics/Epigenetics and Cancer Research. He is also the editorial board member of Frontiers in Oncology and Frontiers in Bioinformatics.
Xin Zhang
Dr. Xin Zhang is Department Director and Principal Investigator of the Clinical Experimental Center at Jiangmen Central Hospital (China). He received his Ph.D. in Molecular Medicine from Sun Yat-sen University in 2016. Dr. Zhang is an enthusiastic, early career scientist involved in interdisciplinary training and has a strong biological background, including molecular pathology, molecular diagnostics, and molecular pharmacology. His current research interests mainly focus on the molecular mechanism of tumor recurrence and metastasis, clinical application of molecular diagnosis, and molecular pharmacological mechanism of traditional Chinese medicine in potential therapeutic application of cancer.